Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Authors: Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal, Linda Morrow, Hanns–Ulrich Marschall, Mark Kipnes, Luciano Adorini, Cathi Sciacca, Paul Clopton, Erin Castelloe, Paul Dillon, Mark Pruzanski, Д. А. Шапиро - Gastroenterology 2013 cited by 915